Ready for rapid rule-out of acute myocardial infarction

Pros and cons of a dual biomarker strategy for patients with a suspected acute myocardial infarction (AMI). Suspected AMI patients are transported to the emergency department (ED) to rule-in or rule-out an AMI. Chest pain is the most common reason for emergency medical contact and ED overcrowding is a growing problem worldwide. To reduce ED overcrowding, the efficiency of the diagnostic pathway of chest pain needs to improve. The AROMI study proposes an accelerated dual biomarker strategy to reduce the length of stay in the ED, which could reduce ED overcrowding. Pre-hospital strategies for rule-out of AMI could also improve the efficiency of the diagnostic pathway of chest pain. Together with pre-hospital strategies, the AROMI study further opens the door to rapid rule-out of AMI.